Study shines new light on genetic alterations of aggressive breast cancer subtype Aug 7, 2014 Researchers find genetic alterations that may contribute to the development of a subtype breast cancer typically associated with more aggressive forms of the disease and higher recurrence rates.
Dr. Malcolm Brenner receives prestigious lifetime achievement honor from Human Gene Therapy journal Aug 5, 2014 Renowned cell and gene therapy clinician-scientist Dr. Malcolm Brenner has received the prestigious Pioneer Award from the journal Human Gene Therapy.
Study profiles parents’ attitudes on genomic studies, data sharing and privacy Mar 11, 2014 Baylor researchers find parents are more concerned about the future risk to their child, when considering enrollment in genetic studies.
Dr. Malcolm Brenner recipient of Pediatric Blood and Marrow Transplant Consortium Lifetime Achievement Award Feb 13, 2014 Renowned cell and gene therapy researcher Dr. Malcolm Brenner has been named a recipient of the Pediatric Blood and Marrow Transplant Consortium’s Lifetime Achievement Award.
Higher risk of cardiovascular disease in African-Americans may stem from hyperactive platelets Nov 10, 2013 Research important in understanding how to use certain drugs and how to personalize drugs based on patient information.
Blood test on horizon to detect aortic aneurysm, dissection Sep 19, 2013 Baylor part of team that has developed a blood test to provide a faster and simpler way to diagnose and monitor deadly aortic aneurysms and dissections.
New options in sickle cell treatment focus on long-term maintenance Sep 9, 2013 Baylor researchers aim at developing more efficient and progressive forms of treatment that could potentially benefit patients around the world.
Baylor receives $960,000 plus in Komen breast cancer grants Aug 1, 2013 Four Baylor College of Medicine researchers received new grant funding from Susan G. Komen for the Cure to help advance breast cancer research.
Love Foundation Award recipient touts mentors, colleagues Jul 8, 2013 Baylor College of Medicine's Dr. Martha Mims has received the Ben and Margaret Love Foundation Bobby Alford Award for Academic Clinical Professionalism, and honors the physicians who trained her.
Phase 1 trial uses enhanced T cells to treat neuroblastoma Jun 10, 2013 A phase 1 clinical trial at Baylor College of Medicine, which has received support from a pediatric cancer nonprofit organization, will use an immunotherapy approach to treating kids with neuroblastoma.